Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Chill Yee MD
Chill C. Yee MD Advisory Board
Jonathan Temte MD, PhD
Jonathan Temte MD, PhD Advisory Board
David Rakel MD, FAAFP
David Rakel MD, FAAFP Editor-in-Chief
See All Experts
featured
Published in Primary Care and
2 other channels

Expert Opinion / Commentary · March 30, 2015

Weighing the Benefits and Risks of Testosterone Replacement Therapy

Culley Carson III MD, FACS, FRCS

 

 Save  Recommend
 Share

Additional Info

  1. Shores MM, Matsumoto AM, Sloan KL, Kiviahan DR. Low serum testosterone and mortality in male veterans.. Arch Intern Med. 2006;166(15):1660-1665.
  2. Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab. 2012;97(6):2050-2058.
  3. Vigen R, O'Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310(17):1829-1836.
  4. Finkle WD, Greenland S, Ridgeway GK, et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One. 2014;9(1):e85805.
  5. Baillargeon J, Urban RJ, Kuo YF, et al. Risk of myocardial infarction in older men receiving testosterone therapy. Ann Pharmacother. 2014;48(9):1138-1144.
  6. US Food and Drug Administration. FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. US Food and Drug Administration Web site.

Further Reading

Most Read This Week

Recently Updated